- Current report filing (8-K)
02 März 2009 - 12:10PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported)
February 26,
2009
Kewaunee
Scientific Corporation
(Exact
name of registrant as specified in its charter)
|
|
|
Delaware
|
0-5286
|
38-0715562
|
|
|
|
(State
or other jurisdiction
of
incorporation)
|
(Commission
File
Number)
|
(I.R.S.
Employer
Identification
No.)
|
2700
West Front Street
Statesville,
North Carolina
(Address
of principal executive offices)
|
28677
(Zip
Code)
|
Registrant’s
telephone number, including area
code 704-873-7202
N/A
(Former
name or former address, if changed since last report.)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item 2.02
Results of Operations and Financial Conditions
On
February 26, 2009, Kewaunee Scientific Corporation issued a press release
announcing its financial results for the third quarter ended January 31,
2009. A copy of the Press Release is furnished as Exhibit 99.1 to
this Current Report on Form 8-K.
Item 9.01
Financial Statements and Exhibits
(d)
Exhibits:
Exhibit
No.
|
99.1
|
Press
Release of Kewaunee Scientific Corporation dated February 26,
2009.
|
In
accordance with General Instruction B.2 of Form 8-K, the information in this
Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”), or otherwise subject to the liabilities of that section,
and shall not be incorporated by reference into any registration statement or
other document filed under the Securities Act of 1933, as amended, or the
Exchange Act, except as shall be expressly set forth by specific reference in
such filing.
Signature
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
(Registrant)
|
|
Kewaunee
Scientific Corporation
|
|
|
Date: February
26, 2009
|
/s/
D. Michael Parker
|
|
D.
Michael Parker
Senior
Vice
President, Finance
|
|
Chief
Financial
Officer
|
Kewaunee Scientific (NASDAQ:KEQU)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Kewaunee Scientific (NASDAQ:KEQU)
Historical Stock Chart
Von Jul 2023 bis Jul 2024